Noema Pharma Ag
Clinical trials sponsored by Noema Pharma Ag, explained in plain language.
-
New drug trial offers hope for reducing Tourette's tics
Symptom relief OngoingThis study is testing whether an experimental drug called gemlapodect can safely reduce tics in people with Tourette Syndrome. About 164 adults and teenagers will take either the drug or a placebo pill daily for 12 weeks to see which works better. Researchers will measure changes…
Phase: PHASE2 • Sponsor: Noema Pharma AG • Aim: Symptom relief
Last updated Mar 23, 2026 15:14 UTC
-
New hope for 'Suicide Disease' pain? experimental drug enters Late-Stage testing
Symptom relief OngoingThis study is testing whether a daily pill called basimglurant can reduce the severe, shock-like facial pain caused by trigeminal neuralgia in adults who don't get enough relief from their current pain medications. About 166 participants will first take the drug for 8 weeks, then…
Phase: PHASE2, PHASE3 • Sponsor: Noema Pharma AG • Aim: Symptom relief
Last updated Feb 17, 2026 14:35 UTC